AstraZeneca plc Mergers and Acquisitions


AstraZeneca plc

15 Stanhope Gate
London W1Y 6LN
United Kingdom
Tel:44/20/7304-5000
URL: http://www.astrazeneca.com
Primary Symbol & Exchange:
AZN - Ordinary Shares - London
Other Symbols & Exchanges:
AZN - ADR - New York Stock Exchange
ZEG - Common Stock - Frankfurt
AZN - Common Stock - Stockholm (Nasdaq OMX Group)
AZNCF - Dual Listed - Other-OTC
Industry:
Pharmaceutical
AstraZeneca plc Company Snapshot

AstraZeneca plc Deal Timeline


Drag the timeline to see more deals; click on a deal to see details.


Acquisitions > 100 M$ 10 to 100 M$ < 10M$ Stakes Divestitures

AstraZeneca plc M&A History


Biofabri SL acquires AstraZeneca PLC-Production from AstraZeneca PLC Biofabri SL acquires  AstraZeneca PLC-Production from AstraZeneca PLCOct 09, 2009

SPAIN - Biofabri SL, a wholly- owned unit of CZ Veterinaria SA, acquired the production site, located in O Porrino, Spain, of AstraZeneca PLC, a London-based manufacturer and wholesaler of pharmaceutical products. Originally, in ## November ####, AstraZeneca announced that

AstraZeneca PLC seeking buyer AstraZeneca PLC seeking buyerSep 28, 2009

UK - In Semptember ####, AstraZeneca PLC, a London- based manufacturer and wholesaler of pharmaceuticals, announced that it was seeking a buyer for the company. Novartis was named potential bidder.

Corden Pharma GmbH acquires AstraZeneca-Prodn Site from AstraZeneca PLC Corden Pharma GmbH acquires  AstraZeneca-Prodn Site from AstraZeneca PLCJul 01, 2009

ITALY - Corden Pharma GmbH of Germany, and a unit of International Chemical Investors GmBH, acquired the production site, located in Milan, Italy, from AstraZeneca PLC, a London- based manufacturer and wholesaler of pharmaceuticals.

GlaxoSmithKline PLC acquires AstraZeneca PLC-OTC Product from AstraZeneca PLC (pending) GlaxoSmithKline PLC acquires AstraZeneca PLC-OTC Product from AstraZeneca PLC (pending)Apr 06, 2009

UK ? GlaxoSmithKline PLC agreed to acquire the OTC product portfolio of AstraZenenca PLC, a London- based manufacturer and wholesaler of pharmaceuticals, for GBP ###.### mil ($### mil).

Minafin SA acquires AstraZeneca PLC-Dunkirk Plant from AstraZeneca PLC (pending) Minafin SA acquires AstraZeneca PLC-Dunkirk Plant from AstraZeneca PLC (pending)Feb 06, 2009

FRANCE - Minafin SA of Luxembourg agreed to acquire the Dunkirk plant of AstraZeneca PLC, a Dunkirk- based manufacturer and wholesaler of pharmaceutical products.

GlaxoSmithKline PLC acquires AZ Tika from AstraZeneca PLC (pending) GlaxoSmithKline PLC acquires AZ Tika from AstraZeneca PLC (pending)Nov 20, 2008

SWEDEN - GlaxoSmithKline PLC of the UK agreed to acquire AZ Tika, a manufacturer and wholesaler of pharmaceutical products, from AstraZeneca PLC, for an estimated #.### bil Swedish kronor (### mil British pounds/$###.### mil US) in cash. The

Recipharm AB acquires AstraZeneca PLC-Swedish from AstraZeneca PLC (pending) Recipharm AB acquires AstraZeneca PLC-Swedish from AstraZeneca PLC (pending)Nov 17, 2008

SWEDEN - Recipharm AB planned to acquire the Swedish biotech manufacturing facility of AstraZeneca PLC, a manufacturer and wholesaler of pharmaceutical products. Terms were not disclosed.

BioPhausia AB acquires Astrazeneca AB-Pharmaceutical from AstraZeneca PLC BioPhausia AB acquires Astrazeneca AB-Pharmaceutical from AstraZeneca PLCJun 30, 2008

SWEDEN - BioPhausia AB acquired the pharmaceutical portfolio of Astrazeneca AB, a Sodertalje-based manufacturer of pharmaceuticals, from AstraZeneca PLC, for ### mil Swedish kronor ($##.## mil US) in cash. The transaction was subject to regulatory and shareholders approvals and

ICIG acquires Astrazeneca PLC-German prodn from AstraZeneca PLC ICIG acquires Astrazeneca PLC-German prodn from AstraZeneca PLCFeb 15, 2008

UK - International Chemical Investors GmbH (IC) acquired the Plankstadt production plant of AstraZeneca (AZ), a London-based pharmaceutical company. Terms were not disclosed. Originally, IC was rumored to be planning to acquire the Plankstadt production plant of AZ.

AstraZeneca PLC spins off AstraZeneca PLC-Gastrointestin (pending) AstraZeneca PLC spins off AstraZeneca PLC-Gastrointestin (pending)Feb 14, 2008

SWEDEN - AstraZeneca PLC planned to spin off its gastrointestinal research operations, located in Gothenburg, to its shareholders. Upon completion, the gastrointestinal research operations was to be renamed Albireo.

AstraZeneca PLC seeking buyer for Astrazeneca-Research Unit AstraZeneca PLC seeking buyer for Astrazeneca-Research UnitFeb 11, 2008

SWEDEN - In February ####, AustraZeneca PLC, announced that it was seeking a buyer for its Stomach and Intestine Disease Research unit, a Gothenberg-based provider of research services. Nordic Capital and EQT were identified as potential buyers.

AstraZeneca PLC acquires NPS Pharmaceuticals Inc- from NPS Pharmaceuticals Inc (pending) AstraZeneca PLC acquires NPS Pharmaceuticals Inc- from NPS Pharmaceuticals Inc (pending)Oct 09, 2007

US - AstraZeneca PLC agreed to acquire the metabotropic glutamate receptors (mGluRs) collaboration assets of NPS Pharmaceuticals Inc, a developer and manufacturer of therapeutic molecules, for $## mil.

Astra Tech AB acquires Atlantis Components Inc Astra Tech AB acquires Atlantis Components IncSep 27, 2007

US - Astra Tech AB, a unit of AstraZeneca AB, acquired Atlantis Components Inc, a manufacturer of dental products, for $## mil in cash.

AstraZeneca PLC acquires Verus Pharm Inc-Pediatric from Verus Pharmaceuticals Inc AstraZeneca PLC acquires Verus Pharm Inc-Pediatric from Verus Pharmaceuticals IncSep 24, 2007

US - AstraZeneca PLC acquired the pediatric asthma development programs of Verus Pharmaceuticals Inc, a manufacturer of pharmaceuticals products, for $### mil. The consideration consisted of $## mil and up to $### mil in profit related payments.

Recipharm AB acquires AstraZeneca PLC-Production, from AstraZeneca PLC Recipharm AB acquires AstraZeneca PLC-Production, from AstraZeneca PLCJul 01, 2007

FRANCE - Recipharm AB of Sweden acquired the production and packaging site of AstraZeneca PLC, a London-based manufacturer and wholesaler of pharmaceuticals. Terms were not disclosed.

AstraZeneca PLC launches a tender offer for MedImmune Inc AstraZeneca PLC launches a tender offer for MedImmune IncJun 18, 2007

US - AstraZeneca PLC completed its tender offer to acquire all the outstanding common stock of MedImmune Inc (MI), a manufacturer of vaccines and a provider of research services, for $## in cash per share, or a total value of $##

AstraZeneca PLC acquires DSM Biologics Inc-Asts from Royal DSM NV AstraZeneca PLC acquires DSM Biologics Inc-Asts from Royal DSM NVJun 04, 2007

CANADA - AstraZeneca PLC acquired the manufacturing facility, located in Montreal, of DSM Biologics Inc, a manufacturer of pharmaceuticals and a jointly-owned unit of DSM Pharmaceutical Products and Societe Generale de Financement du Quebec.

Astrazeneca AB acquires Recip AB-Real Estate from Recip AB Astrazeneca AB acquires Recip AB-Real Estate from Recip ABJun 01, 2007

SWITZERLAND - AstraZeneca AB acquired ## real estate properties of Recip AB, a Haninge-based manufacturer of pharmaceuticals.

AstraZeneca PLC acquires Arrow Therapeutics Ltd AstraZeneca PLC acquires Arrow Therapeutics LtdMar 02, 2007

UK - AstraZeneca PLC acquired the entire share capital of Arrow Therapeutics Ltd, a London-based manufacturer of pharmaceuticals, for ##.### mil British pounds ($### mil US) in cash.

Cargill Inc acquires a minority stake in Assets Care Enterprise Ltd (pending) Cargill Inc acquires a minority stake in Assets Care Enterprise Ltd (pending)Jan 30, 2007

INDIA - Cargill Inc planned to acquire a ##% stake in Assets Care Enterprise Ltd, an investment management services provider.

AstraZeneca plc M&A Summary


AstraZeneca plc has made 33 acquisitions while taking stakes in 8 companies. AstraZeneca plc has 40 divestitures during this period.
YearAcquisitionsStakesDivestitures
2009002
2008002
2007601
2006303
2005100
2004113
2003001
2002000
2001214
2000004
1999225
1998501
1997202
1996304
1995321
1994023
1993003
1992001
1991200
1990200
1989000
1988100
Total33840

Other Recent M&A in the Pharmaceutical industry